Connect Biopharma Holdings LTD Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
SCHEDULE 13D/A: Panacea Venture Reduces Connect Biopharma Stake to 21.5%
Panacea Venture Healthcare Fund II, L.P. has reduced its beneficial ownership in Connect Biopharma Holdings Limited by selling 2,000,000 Ordinary Shares at $3.00 per share, now holding 21.5%.
NASDAQ
Panacea Venture Healthcare Fund II, L.P. has increased its beneficial ownership in Connect Biopharma Holdings Limited to 25.1% through recent open market purchases of American Depositary Shares.